Nondiabetic kidney diseases in type 2 diabetic patients

Ye-Jin KIM; Yoo-Hyung KIM; Ki-Dae KIM; Kang-Ryun MOON; Jae-Ho PARK; Bo-Mi PARK; Hyewon RYU; Dae-Eun CHOI; Ki-Ryang NA; Kwang-Sun SUH; Kang-Wook LEE; Young-Tai SHIN.
Kidney Research and Clinical Practice ; : 115-120, 2013.
Artículo en Inglés | WPRIM | ID: wpr-92916

Documentos relacionados

  1. Novel Antigens and Clinical Updates in Membranous Nephropathy.
  2. Subepithelial deposits with microspherular structures in membranous glomerulonephritis.
  3. A nomogram prediction model for treatment failure in primary membranous nephropathy.
  4. Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification.
  5. Anti-phospholipase A2 receptor positive membranous nephropathy: investigating the link between electron microscopy stages and clinical outcome.
  6. Effectiveness of a novel rat model of off-target PLA2R1 knockout to renal impairment.
  7. Clinicopathological characteristics and outcomes of PLA2R related idiopathic membranous nephropathy in patients with seronegative PLA2R antibodies.
  8. Advances in antigens associated with Idiopathic Membranous Nephropathy.
  9. The expanding spectrum and utility of antigens in membranous nephropathy.
  10. Seropositive PLA2R-associated membranous nephropathy but biopsy-negative PLA2R staining.